Results 1 to 10 of about 918,808 (119)

Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. [PDF]

PLoS ONE, 2011
The CA 19-9 assay detects a carbohydrate antigen on multiple protein carriers, some of which may be preferential carriers of the antigen in cancer. We tested the hypothesis that the measurement of the CA 19-9 antigen on individual proteins could improve ...
Tingting Yue, Kevin A Maupin, Brian Fallon, Lin Li, Katie Partyka, Michelle A Anderson, Dean E Brenner, Karen Kaul, Herbert Zeh, A James Moser, Diane M Simeone, Ziding Feng, Randall E Brand, Brian B Haab   +13 more
doaj   +2 more sources

The prognostic value of postoperative tumor marker conversion for gastric cancer [PDF]

Korean Journal of Clinical Oncology, 2020
Purpose Preoperative positivity of serum tumor markers has been associated with poor long-term survival among patients with gastric cancer. However, there have been a considerable number of patients who have experienced a normalization of tumor markers ...
Jeongju Noh, Ki Bum Park, Oh Kyoung Kwon
doaj   +1 more source

Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy

Asian Journal of Surgery, 2021
Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma ...
Sang Hun Park, Jun Ho Shin, Kyung Uk Jung, Sung Ryol Lee   +3 more
doaj   +1 more source

CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade? [PDF]

Journal of Clinical and Diagnostic Research, 2022
Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with ...
Julie H John, R Sanghamita, Ajay Halder, Sramana Mukhopadhyay, Shweta Patel   +4 more
doaj   +1 more source

Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression

Journal of Evidence-Based Integrative Medicine, 2023
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors.
Abd AlRahman Mohammad Foda MD, Tarek Atia MD, Hader I. Sakr MD, Khaled Abd Elaziz Ahmed Elnaghi MD, Wagih M. Abdelhay MD, Eman T. Enan MD   +5 more
doaj   +1 more source

Pancreatic Tuberculosis with Markedly Elevated CA 19-9 Levels: A Diagnostic Pitfall

Oman Medical Journal, 2016
Despite the high prevalence of tuberculosis (TB) in developing countries, isolated pancreatic TB is rare and is usually seen in immunocompromised patients.
Manveen Kaur, Varsha Dalal, Amar Bhatnagar, Fouzia Siraj   +3 more
doaj   +1 more source

A giant ovarian mucinous tumor in a 58-year-old postmenopausal patient with persistent abdominal pain and high serum levels of CA 19-9

The Pan African Medical Journal, 2020
Ovarian cancer is the seventh most commonly diagnosed cancer among women in the world and epithelial ovarian cancer is the most predominant pathologic subtype.
Francesk Mulita, Nikoleta Oikonomou, Levan Tchabashvili, Elias Liolis, Ioannis Kehagias   +4 more
doaj   +1 more source

Serum carcinoembryonic antigen tends to decrease in poorly-differentiated colorectal cancer

Universa Medicina, 2015
BACKGROUND Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 are tumor markers for colorectal cancer (CRC), both having prognostic value.
Ester Morina Silalahi, Lukman Hakim Zain, Rustam Effendi   +2 more
doaj   +1 more source

Predictors of malignancy in pancreatic head mass: a prospective study

The Pan African Medical Journal, 2011
INTRODUCTION: The objective of the study was to identify the predictive factors for malignancy in pancreatic head mass as a primary outcome and assess the value of CA 19-9 as a diagnostic tool for malignancy as a secondary outcome.
Arjun Sivaraman, Ashok Muthukrishnan, Nagendra Boopathy Senguttvan, Suraj Anil Suchak, Umashankkar Kannan   +4 more
doaj   +1 more source

Elevated CEA and CA 19-9 Levels within the Normal Ranges Increase the Likelihood of CRC Recurrence in the Chinese Han Population

Applied Bionics and Biomechanics, 2022
Objective. This study aimed to determine if variations in the expression profiles of CA 19-9 and carcinoembryonic antigen (CEA) within the reference range could serve as possible biomarkers for postoperative CRC recurrence. Method.
Lujia Wang, Guangkai Zhang, Jiafeng Shen, Yujiang Shen, Guojun Cai   +4 more
doaj   +1 more source